trans-2-phenylcyclopropane-1-carboxylic acid, 97.0%, 5g

5-(3-chlorophenyl)-1,3,4-oxadiazole-2-thiol, 95.0%, 2.5g

[1,1'-Biphenyl]-2-amine, 97.0%, 5g

BENZYL (2-(4-(TRIFLUOROMETHYL)-1H-IMIDAZOL-1-YL)ETHYL)CARBAMATE, 95.0%, 250mg

1-Bromo-3-(prop-2-yn-1-yloxy)benzene, 97%, 250mg

4-phenyltetrahydro-2H-pyran-4-carbonitrile, 95.0%, 1g

Cyclopropanecarboxamide, N-[6-[4-[[[[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-4-pyrimidinyl]-, 98%, 5mg

1,2-Dichlorobenzene, min 98%, for synthesis, 1L, glass packaging

(5-Fluoro-2-nitrophenyl)(2,4,6-trimethoxyphenyl)iodonium p-Toluenesulfonate, >95.0%(HPLC), 100mg

Ecabet, 95.0%, 250mg

2-Amino-6-azaspiro[3.4]octan-5-one hydrochloride, 98%, 100mg

N'-?Methyl-?N'-?phenylbenzohydrazide, 95.0%, 25mg

1-(2-Bromophenyl)cyclobutane-1-carboxylic acid, 95.0%, 1g